Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of activated type I receptor tyrosine kinases in early breast cancer.
Spears M, Pederson HC, Lyttle N, Gray C, Quintayo MA, Brogan L, J Thomas JS, Kerr GR, Jack WJ, Kunkler IH, Cameron DA, Chetty U, Bartlett JM. Spears M, et al. Among authors: bartlett jm. Breast Cancer Res Treat. 2012 Jul;134(2):701-8. doi: 10.1007/s10549-012-2076-7. Epub 2012 May 5. Breast Cancer Res Treat. 2012. PMID: 22562124
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue.
Carder PJ, Murphy CE, Dervan P, Kennedy M, McCann A, Saunders PT, Shaaban AM, Foster CS, Witton CJ, Bartlett JM, Walker RA, Speirs V. Carder PJ, et al. Among authors: bartlett jm. Breast Cancer Res Treat. 2005 Aug;92(3):287-93. doi: 10.1007/s10549-004-4262-8. Breast Cancer Res Treat. 2005. PMID: 16155800
Bad expression predicts outcome in patients treated with tamoxifen.
Cannings E, Kirkegaard T, Tovey SM, Dunne B, Cooke TG, Bartlett JM. Cannings E, et al. Among authors: bartlett jm. Breast Cancer Res Treat. 2007 Apr;102(2):173-9. doi: 10.1007/s10549-006-9323-8. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004114
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P. Bartlett JM, et al. J Clin Oncol. 2007 Oct 1;25(28):4423-30. doi: 10.1200/JCO.2007.11.0973. J Clin Oncol. 2007. PMID: 17906205
331 results